Literatur
-
1
Bumming P, Andersson J, Meis-Kindblom J M. et al .
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.
Br J Cancer.
2003;
89
460-464
-
2
DeMatteo R P, Lewis J J, Leung D, Mudan S S, Woodruff J M, Brennan M F.
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.
Ann Surg.
2000;
231
51-58
-
3
Fletcher C DM, Berman J J, Gorless C. et al .
Diagnosis of gastrointestinal stromal tumors: A consensus approach.
Hum Pathol.
2002;
33
459-465
-
4
Heinrich M C, Corless C L, Demetri G.
Kinase Mutations and Imatinib response in patients with metastatic gastro-intestinal stromal tumors.
J Clin Oncol.
2003;
21
4342-4349
-
5
Hirota S, Isozaki K, Moriyama Y. et al .
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
Science.
1998;
279
577-580
-
6
Hohenberger P.
Neue Konzepte der Chirurgischen Therapie gastrointestinaler Stromatumoren.
Viszeralchirurgie.
2003;
38
379-386
-
7
Hohenberger P, Schneider U, Rötzschke O, Pink D, Reichardt P.
Resection of progressive or residual tumor following treatment with imatinib for advanced GI stromal tumors.
Ann Surg Oncol.
2004;
11
(im Druck)
-
8
Jost D, Stroszczynski C, Chmelik P G. et al .
Morphologie gastrointestinaler Stromatumoren im fortgeschrittenen Stadium der Erkrankung: Ausgangsbefunde vor Chemotherapie mit Imatinib.
Fortschr Röntgenstr.
2003;
175
791-798
-
9
Reichardt P, Pink D, Mrozek A, Lindner T, Hohenberger P.
Gastro-Intestinale Stromatumoren (GIST).
Z Gastroenterol.
2004;
42
327-332
-
10
Reichardt P, Schneider U, Stroszczynski C, Pink D, Hohenberger P.
Histological response of gastrointestinal stromal tumor to treatment with tyrosine kinase inhibitor imatinib mesylate.
J Clin Pathol.
2004;
57
215-217
-
11
Singer S, Rubin B P, Lux M L. et al .
Prognostic Value of KIT Mutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal Tumors.
J Clin Oncol.
2002;
20
3898-3905
-
12
Wardelmann E, Hrychyk A, Merkelbach-Bruse S. et al .
Histology and location of gastrointestinal stromal tumors correlate with the mutational status of platelet-derived growth factor receptor alpha.
J Mol Diagn.
2004;
6
197-204
Prof. Dr. med. Peter Hohenberger
Sektion Chirurgische Onkologie und Thoraxchirurgie, Chirurgische Univ.-Klinik, Fakultät Klinische Medizin Mannheim, Universität Heidelberg
Theodor Kutzer Ufer 1
68135 Mannheim
Phone: 0621/3832609
Fax: 0621/3832357
Email: peter.hohenberger@chir.ma.uni-heidelberg.de
